Solasia Pharma K.K.
TSE:4597.T
49 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -1,112 | -2,492 | -2,442 | -4,159 | -1,797 | -2,445 | -1,016.285 | -494.639 | -710.757 | -701.982 |
| Depreciation & Amortization
| 500 | 534 | 495 | 496 | 475 | 153 | 0.527 | 0.882 | 0.94 | 0.462 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 307 | -525 | -571 | 64 | 451 | 15 | 118.398 | -2.938 | -1.752 | 75.714 |
| Accounts Receivables
| 540 | -446 | 51 | -160 | 182 | -174 | -17.353 | 8.635 | -0.9 | 0 |
| Inventory
| -108 | -14 | 4 | -1 | 118 | -28 | -25.606 | -67.685 | 0 | 0 |
| Accounts Payables
| -118 | -65 | -626 | 225 | 151 | 217 | 161.357 | 0 | 0 | 0 |
| Other Working Capital
| -7 | -13 | 47 | -18 | 7 | 43 | 144.004 | 64.747 | 2.594 | 0 |
| Other Non Cash Items
| -54 | 409 | 45 | 810 | 43 | -46 | -14.034 | 31.706 | 11.944 | -6.013 |
| Operating Cash Flow
| -359 | -2,074 | -2,473 | -2,789 | -828 | -2,323 | -911.394 | -464.989 | -699.625 | -631.819 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | -403 | -163 | -171 | -732 | -257 | -499.099 | -557.625 | -633.425 | -149.883 |
| Acquisitions Net
| 0 | -14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -1 | -1 | -161 | -3 | 1 | -38.122 | -0.11 | 0.093 | 0.84 |
| Investing Cash Flow
| 2 | -418 | -164 | -171 | -735 | -256 | -537.221 | -557.735 | -633.332 | -149.043 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | -500 | -1,000 | -1,500 | 0 | 0 | 0 | 0 | -1,543.75 | 0 |
| Common Stock Issued
| 318 | 2,618 | 1,403 | 861 | 1,704 | 3,309 | 3,782.182 | 6.722 | 1,390.048 | 11.999 |
| Common Stock Repurchased
| 0 | -3 | 0 | 0 | -22 | -48 | 0 | -14.577 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -43 | 459 | -42 | 2,468 | -41 | -1 | -0.264 | -25.763 | 1,543.685 | 823.823 |
| Financing Cash Flow
| 275 | 2,571 | 361 | 1,829 | 1,641 | 3,260 | 3,781.918 | -33.618 | 2,933.733 | 835.822 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 7 | 10 | 25 | -20 | -6 | -4 | -2.147 | -4.206 | -2.472 | 4.354 |
| Net Change In Cash
| -75 | 89 | -2,250 | -1,152 | 70 | 676 | 2,331.154 | -1,060.551 | 1,598.303 | 59.315 |
| Cash At End Of Period
| 728 | 803 | 714 | 2,964 | 4,116 | 4,046 | 3,370.15 | 1,038.996 | 2,099.547 | 501.244 |